Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2001
04/12/2001CA2388706A1 Detection of prostate cancer measuring psa/igf-1 ratio
04/12/2001CA2388408A1 Prevention and treatment of diseases associated with blood coagulation
04/12/2001CA2388384A1 Protein fingerprint system and related methods
04/12/2001CA2387992A1 Method of manufacture of colloidal rod particles as nanobar codes
04/12/2001CA2386820A1 Removal of dye-labeled dideoxy terminators from dna sequencing reactions
04/12/2001CA2386669A1 Prostate cancer marker proteins
04/12/2001CA2386540A1 Novel carbamates and ureas
04/12/2001CA2386499A1 Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions
04/12/2001CA2386383A1 Growth factor polypeptides and nucleic acids encoding same
04/12/2001CA2386252A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein
04/12/2001CA2386249A1 Biosensor and its use to indicate the status of a product
04/12/2001CA2386239A1 Methods for identifying rna binding compounds
04/12/2001CA2386236A1 Human inwardly rectifying potassium channel subunit
04/12/2001CA2386199A1 Endozepine-like polypeptides and polynucleotides encoding same
04/12/2001CA2386189A1 Novel human membrane proteins
04/12/2001CA2386186A1 Surface enhanced spectroscopy-active composite nanoparticles
04/12/2001CA2386165A1 Methods of imaging colloidal rod particles as nanobar codes
04/12/2001CA2386093A1 Fluid-flow control device
04/12/2001CA2386089A1 Diagnostic and therapeutic epitope and transgenic plant
04/12/2001CA2386047A1 Colloidal rod particles as nanobar codes
04/12/2001CA2385875A1 Gmp synthetase derived from plants
04/12/2001CA2385703A1 Plasminogen-like polynucleotides, polypeptides, and antibodies
04/12/2001CA2385536A1 Device and method for controlling the quality of microdroplets deposited on a substrate
04/12/2001CA2385323A1 Cellulose films for screening
04/12/2001CA2385032A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof
04/12/2001CA2382859A1 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization
04/12/2001CA2380807A1 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same
04/12/2001CA2379462A1 Human g-protein coupled receptor
04/12/2001CA2378008A1 Systems and methods for characterizing a biological condition or agent using calibrated gene expression profiles
04/12/2001CA2322936A1 Bisphosphonic acid derivative and compound thereof labeled with radioactive nuclide
04/11/2001EP1091211A1 Metal chelate containing compositions for use in chemiluminescent assays
04/11/2001EP1091210A1 Conditioning means to analyse a polluted soil sample and analysing method using pyrolysis using said means
04/11/2001EP1091205A2 Spectrophotometric and nephelometric detecting system
04/11/2001EP1090997A1 Hcv-derived rna polymerase gene
04/11/2001EP1090995A2 Mycoplasma hyopneumoniae antigen MHP3, gene encoding it and uses thereof
04/11/2001EP1090991A1 Novel nicotinic acetylcholine receptor subunit, its isolation and use
04/11/2001EP1090989A1 Human g-protein-coupled receptor
04/11/2001EP1090986A1 Protein rim 2
04/11/2001EP1090985A1 Feline-derived T-cells
04/11/2001EP1090927A1 Polypeptide (scFv) for the detection and removal of CA19-9 antigen positive cells
04/11/2001EP1090926A1 Human G-protein coupled receptor
04/11/2001EP1090924A1 Tumor antigen peptides originating in cyclophilin b
04/11/2001EP1090301A1 Non-invasive transdermal detection of analytes
04/11/2001EP1090300A1 Assay to indicate the presence of non-fertilisable ova
04/11/2001EP1090299A1 Methods of detecting t-cell activation
04/11/2001EP1090298A1 Improved binding assays through multiepitope analysis and combined antigen and antibody determination
04/11/2001EP1090297A2 Method of detecting an antibody in a liquid sample
04/11/2001EP1090296A1 Analyte assay device
04/11/2001EP1090295A1 Methods for rapidly identifying small organic ligands
04/11/2001EP1090294A1 Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptides derived from said ssx gene and ny-eso-1 gene, and uses thereof
04/11/2001EP1090293A2 Decoding of array sensors with microspheres
04/11/2001EP1090292A1 Use of rev-erb family of receptors in screening
04/11/2001EP1090290A1 Analysis of liquid samples
04/11/2001EP1090286A1 Multi-sensor array for electrochemical recognition of nucleotide sequences and methods
04/11/2001EP1090279A2 Screening method for dehydrogenase oligomerisation modulators
04/11/2001EP1090145A2 Binding acceleration techniques for the detection of analytes
04/11/2001EP1090143A1 Method for quantifying tgf-beta
04/11/2001EP1090142A1 Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith
04/11/2001EP1090135A2 Methods to screen herbicidal compounds utilizing air synthetase from arabidopsis thaliana
04/11/2001EP1090119A2 Novel olfactory receptors and their uses
04/11/2001EP1090118A2 Human signal peptide-containing proteins
04/11/2001EP1090116A2 Transgenic non-human animal which comprises an inactive peg3 gene, and the use thereof
04/11/2001EP1090110A2 Human vault rna
04/11/2001EP1090104A1 Methods of expanding and selecting disease associated t-cells
04/11/2001EP1090073A1 Xanthene dyes and their application as luminescence quenching compounds
04/11/2001EP1090038A2 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore
04/11/2001EP1090033A1 Particles of hcv envelope proteins: use for vaccination
04/11/2001EP1090032A2 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
04/11/2001EP1090007A2 Cinoxacin lanthanide chelates and their use as biomolecular probes
04/11/2001EP1089800A1 Filtration and extraction device and method of using the same
04/11/2001EP1089794A2 Methods for inhibiting tef-3 activity
04/11/2001EP1089770A1 Disposable waste management device
04/11/2001EP1089759A1 Synthetic peptide vaccines for foot-and-mouth disease
04/11/2001EP1089756A1 CORRELATIVE PROTECTION USING OspA ANTIBODY TITERS
04/11/2001EP1089749A1 Novel therapeutic agents for membrane transporters
04/11/2001EP0912597A4 Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
04/11/2001EP0904538A4 Method of diagnosis and treatment of atherosclerosis using anti-cholesterol antibodies
04/11/2001EP0897391A4 Recombinant antigens useful for the serodiagnosis of neosporosis
04/11/2001CN1291231A Human telomerase catalytic subunit
04/11/2001CN1291229A Recombinant active human zona pellucida protein 3 (h2P3)
04/11/2001CN1291227A Sperm analysis system
04/11/2001CN1291199A Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production
04/11/2001CN1291096A Use of inhibitors for treatment of disorders related to RTK hyperfunction
04/11/2001CN1290752A Compound micro path array chip and its preparing method
04/10/2001US6216049 Computerized method and apparatus for analyzing nucleic acid assay readings
04/10/2001US6215892 Method and apparatus for automated image analysis of biological specimens
04/10/2001US6215554 Laser diagnostic unit for detecting carcinosis
04/10/2001US6215407 Hydrocarbon detection, alert, and vapor removal system with discharge containment capabilities
04/10/2001US6215317 Method and apparatus for measuring in-place density and moisture content
04/10/2001US6215040 IL-5 transgenic mouse
04/10/2001US6214983 Isolated nucleic acid molecules which encode SCP proteins
04/10/2001US6214972 Human receptor of defined amino acid sequence; for recombinant preparation of membranes for screening agonists and antagonists; treatment of sleep disorders, allergic rhinitis, glaucoma, congestive heart failure; antiinflammatory agents
04/10/2001US6214970 Hepatitis E virus antigens and uses therefor
04/10/2001US6214794 Proliferation or differentiation of nonpost mitotic neuronal cells with polypeptides
04/10/2001US6214629 Enables rapid and efficient flow of fluid by configuring porous channels so that there is no opportunity for stagnation; fluid enters detection zone from sample circulation channel from multitude of points
04/10/2001US6214628 Method of conducting an assay of a sample containing an analyte of interest
04/10/2001US6214625 Composition and method for differentiation of basophils and eosinophils in blood
04/10/2001US6214624 Determining adulteration of gasolines, lubricants or greases by incorporating at least two tracers into product, analyzing possibly adulterated tagged product to determine presence and amount of tracers, comparing to standards
04/10/2001US6214616 Homozygous p53 gene-defective human colonic cell line
04/10/2001US6214600 Polypeptide of defined amino acid sequence; treatment of alzheimer's disease, stroke, musculoskeletal disease, heart disease, kidney disease; anticarcinogenic/antiinflammatory agents; antiarthritic agents; diagnosis